Literature DB >> 19188173

A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.

Laurent Zini1, Vincent Cloutier, Hendrik Isbarn, Paul Perrotte, Umberto Capitanio, Claudio Jeldres, Shahrokh F Shariat, Fred Saad, Philippe Arjane, Alain Duclos, Jean-Baptiste Lattouf, Francesco Montorsi, Pierre I Karakiewicz.   

Abstract

PURPOSE: Cancer-specific mortality (CSM) of patients with primary penile squamous cell carcinoma (PPSCC) may be quite variable. Recently, a nomogram was developed to provide standardized and individualized mortality predictions. Unfortunately, it relies on a large number (n = 8) of specific variables that are unavailable in routine clinical practice. We attempted to develop a simpler prediction rule with at least equal accuracy in predicting CSM after surgical removal of PPSCC. EXPERIMENTAL
DESIGN: The predictive rule was developed on a cohort of 856 patients identified in the 1988 to 2004 Surveillance, Epidemiology and End Results (SEER) database. The predictors consisted of age, race, SEER stage (localized versus regional versus metastatic), tumor grade, type of surgery (excisional biopsy, partial penectomy, and radical penectomy), and of lymph node status (pN0 versus pN1-3 versus pNx). A look-up table based on Cox regression model-derived coefficients was used for prediction of 5-year CSM. The predictive rule accuracy was tested using the Harrell's modification of the area under the receiver operating characteristics curve.
RESULTS: SEER stage and histologic grade achieved independent predictor status and qualified for inclusion in the model. The model achieved 73.8% accuracy for prediction of CSM at 5 years after surgery. Both predictors achieved independent predictor status in competing risk regression models addressing CSM, where other cause mortality was controlled for.
CONCLUSION: Despite equivalent accuracy, our predictive rule predicting 5-year CSM in patients with PPSCC is substantially less complex (2 versus 8 variables) than the previously published model.

Entities:  

Mesh:

Year:  2009        PMID: 19188173     DOI: 10.1158/1078-0432.CCR-08-1888

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  9 in total

1.  Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression.

Authors:  Mark W Ball; Stephania M Bezerra; Alcides Chaux; Sheila F Faraj; Nilda Gonzalez-Roibon; Enrico Munari; Rajni Sharma; Trinity J Bivalacqua; George J Netto; Arthur L Burnett
Journal:  Urology       Date:  2016-02-18       Impact factor: 2.649

Review 2.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

3.  Contemporary management of penile cancer: greater than 15 year MSKCC experience.

Authors:  Kelvin A Moses; Andrew Winer; John P Sfakianos; Stephen A Poon; Matthew Kent; Melanie Bernstein; Paul Russo; Guido Dalbagni
Journal:  Can J Urol       Date:  2014-04       Impact factor: 1.344

4.  Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram.

Authors:  D R Yates; V Hupertan; P Colin; A Ouzzane; A Descazeaud; J A Long; G Pignot; S Crouzet; F Rozet; Y Neuzillet; M Soulie; T Bodin; A Valeri; O Cussenot; M Rouprêt
Journal:  Br J Cancer       Date:  2012-02-28       Impact factor: 7.640

5.  Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma.

Authors:  Limin Yang; Tetsuya Takimoto; Junichiro Fujimoto
Journal:  BMC Cancer       Date:  2014-09-05       Impact factor: 4.430

6.  The Development and Validation of a Nomogram Incorporating Clinical, Pathological, and Therapeutic Features to Predict Overall Survival in Patients With Penile Cancer: A SEER-Based Study.

Authors:  Ruidan Li; Ke Cheng; Zhigong Wei; Zheran Liu; Xingchen Peng
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

7.  External validation of nomograms for predicting cancer-specific mortality in penile cancer patients treated with definitive surgery.

Authors:  Yao Zhu; Wei-Jie Gu; Ding-Wei Ye; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen
Journal:  Chin J Cancer       Date:  2014-02-19

8.  Nomogram prediction of overall survival based on log odds of positive lymph nodes for patients with penile squamous cell carcinoma.

Authors:  Wenwen Zheng; Kangqi Li; Weiwei Zhu; Yuexia Ding; Qingna Wu; Qiling Tang; Congxiao Lu; Quan Zhao; Shengqiang Yu; Chenyu Guo
Journal:  Cancer Med       Date:  2020-06-10       Impact factor: 4.452

9.  A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer.

Authors:  Yifan Wang; Lutao Du; Xuemei Yang; Juan Li; Peilong Li; Yinghui Zhao; Weili Duan; Yingjie Chen; Yunshan Wang; Haiting Mao; Chuanxin Wang
Journal:  Aging (Albany NY)       Date:  2020-02-12       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.